Estimating the potential annual welfare impact of innovative drugs in use in Switzerland

• Hoofdauteurs: Matea ePavic (Auteur), Alena ePfeil (Auteur), Thomas eSzucs (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2014-05-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Expenditures of health care systems are increasing from year to year. Therefore, this study aimed to estimate the difference in costs and benefits of innovative pharmaceuticals launched 2000 onwards compared to standard treatment on the national economy of Switzerland in 2010. The approach and formu...